Associated Papers
A prospective, multicenter, comprehensive genomic profile signature study in patients with EGFR-mutant advanced non-small cell lung cancer at the first-line treatment failure of osimertinib.
Shi Y et al.
Signal Transduction and Targeted Therapy, 2025
41326340 (PubMed )
Supplement: 41392_2025_2481_MOESM1_ESM.docx
Clinical reliability of genomic data obtained from spinal metastatic tumor samples.
Barzilai O et al.
Neuro-oncology, 2022
Mutant p53-Associated Molecular Mechanisms of ROS Regulation in Cancer Cells.
Cordani M et al.
Biomolecules, 2020
Mutant p53 in cancer: new functions and therapeutic opportunities.
Muller PA et al.
Cancer Cell, 2014
Select a paper to view details